MyDx Inc. (OTCQB: MYDX)Detailed Quote · Free Stock Analysis
MyDx Inc. (OTCQB: MYDX) is a science and technology company based in San Diego, California, whose mission is to help people Trust & Verify™ what they put into their minds and bodies. The Company has developed MyDx™, an affordable portable analyzer that provides real-time chemical analysis and fits in the palm of your hands. MyDx™ leverages over a decade of established electronic nose technology to measure chemicals of interest and has four sensors being developed in its lab that are compatible with the MyDx™ Analyzer and App. For more information, please visit www.cdxlife.com.
$50 Discount: Use CFN50 Coupon Code
MyDx Analyzer Commercial:
MYDX Analyzer Product Unboxing:
MYDX Analyzer Product Demo:
About Daniel Yazbeck:
Daniel Yazbeck is on a mission to help people Trust & Verify what they put into their minds and bodies. He founded the Yazbeck Consulting & Investment Group in 2007, which later became the seed investor in CDx, Inc – the makers of MyDx, the world’s first handheld chemical analyzer that will empower end consumers to test the safety and potency of everything they eat, drink and inhale. Daniel comes with over 13 years of experience helping some of the top Fortune 500 companies grow, including Pfizer Pharmaceuticals as a Scientist specializing in Chemical R&D Technologies as well as Panasonic, spearheading their new Market, Business and Strategic Product Development activities in the consumer electronics healthcare field. Daniel holds a Master’s Degree in Medicinal Chemistry from McGill University, with a minor in Marketing, and is an inventor and author on several world patents and research publications. To learn more, please visit www.yazbeckinvestments.com.
Around the Web
- MyDx Releases Earnings Call Investor Presentation
- MyDx Announces Fiscal Year 2016 Results
- Mydx Rockets 4th Quarter Results, Positioning Itself as The Preeminent Data Analytics Platform in The Cannabis Industry
- MyDx, Inc. Announces Top 10 Tracked Cannabis Therapies; Top 10 Patient Communities Supporting Cannabis Therapeutics
- MYDX Achieves 40,000+ Cannabis Consumer Generated Pre-Clinical Data Points Growing at 100% Year Over Year
Follow Us on Social Media
About CFN Media
CFN Media (CannabisFN) is the leading creative agency and media network dedicated to legal cannabis. We help marijuana businesses attract investors, customers (B2B, B2C), capital, and media visibility. Private and public marijuana companies and brands in the US and Canada rely on CFN Media to grow and succeed.
CFN launched in June of 2013 to initially serve the growing universe of publicly traded marijuana companies across North America. Today, CFN Media is also the digital media choice for the emerging brands in the space.
Disclaimer: Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. Emerging Growth LLC dba TDM Financial, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. Emerging Growth LLC dba TDM Financial, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. Emerging Growth LLC dba TDM Financial, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: http://www.cannabisfn.com/legal-disclaimer/.